Innovation Pharmaceuticals
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$3,168,000 over the previous period. Total operating expenses were $3,111,000.

Profit Margin

Innovation Pharmaceuticals Inc. (OTC:IPIX): Profit margin
2014 0 -8.24M
2015 0 -13.14M
2016 0 -12.85M
2017 0 -15.53M
2018 0 -16.36M
2019 0 -9.07M
2020 423K -7.01M -1657.21%
2021 0 -18.72M
2022 18K -7.16M -39783.33%
2023 0 -3.16M

IPIX Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
018K0423K000000
Cost of revenue
373K382K378K0371K413K406K420K00
Gross profit
-373K-364K-378K423K-371K-413K-406K-420K00
Operating exp.
Research and development
1.08M4.81M7.01M2.79M4.34M11.36M12.78M8.95M10.53M6.34M
Selling and marketing
5K29K141K377K100K00000
Total operating expenses
3.11M6.77M9.01M5.05M6.45M13.94M15.33M12.00M12.95M8.03M
Operating income
-3.11M-6.92M-9.01M-4.63M-6.45M-13.94M-15.33M-12.65M-12.95M-8.03M
Other income (expenses), net
-57K-120K-4.85M-2.01M-2.23M-165K-200K-648K-189K-209K
Income before tax
-3.16M-7.04M-13.87M-6.64M-8.68M-16.36M-15.53M-12.85M-13.14M-8.24M
Income tax expense
0120K4.85M362K390K-2.21M198K202K202K1K
Net income
-3.16M-7.16M-18.72M-7.01M-9.07M-16.36M-15.53M-12.85M-13.14M-8.24M
Earnings per share
Basic EPS
-0.00-0.01-0.04-0.02-0.05-0.11-0.12-0.11-0.11-0.08
Diluted EPS
-0.00-0.01-0.04-0.02-0.05-0.11-0.12-0.11-0.11-0.07
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source